Clinical Trial Update: Dexmedetomidine for Sedation in Total Knee Replacements [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dexmedetomidine for sedation in total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of Saskatchewan | Conditions: Post-operative Pain for Total Knee Arthroplasty | Phase 3 | Status: COMPLETED